fingolimod hydrochloride has been researched along with urethane in 3 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (urethane) | Trials (urethane) | Recent Studies (post-2010) (urethane) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 4,986 | 36 | 705 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueno, V; Cordeiro, JA; Cury, PM; Lucas da Silva, LB; Ribeiro, DA | 1 |
| Bueno, V; Cordeiro, JA; Cury, PM; Oshima, CT; Salinas, NR | 1 |
| Bueno, V; Lopes, CT; Oshima, CT; Palma, PV; Salinas, NR | 1 |
3 other study(ies) available for fingolimod hydrochloride and urethane
| Article | Year |
|---|---|
FTY720 treatment in experimentally urethane-induced lung tumors.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Anticarcinogenic Agents; Carcinogens; Disease Models, Animal; Fingolimod Hydrochloride; Leukocytes, Mononuclear; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Propylene Glycols; Sphingosine; Spleen; Urethane | 2008 |
FTY720 and lung tumor development.
Topics: Adenoma; Animals; Fingolimod Hydrochloride; Immunosuppressive Agents; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Proliferating Cell Nuclear Antigen; Propylene Glycols; Sphingosine; Urethane; Vascular Endothelial Growth Factor A | 2009 |
Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720.
Topics: Adenoma; Animals; Apoptosis; Caspase 3; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Lung; Lung Neoplasms; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Proliferating Cell Nuclear Antigen; Propylene Glycols; Sphingosine; Urethane | 2009 |